The answer isn't straightforwardtreatment duration depends on your underlying condition, treatment goals, response to therapy, and ability to maintain improvements through lifestyle changes
The pathogenesis of endocrine manifestations in these contexts often remains unclear, highlighting the need for further studies to elucidate the biochemical and biological mechanisms underlying these interactions
Nevertheless, these mutations affect mainly 4 pathways: proliferative, anti-apoptotic, senescence and cell interactions pathways
At Modera, every patient undergoes a health evaluation before starting any protocol, and our physicians discuss the relevant research, benefits, and risks of each therapy during your consultation
Inhibition of dipeptidyl peptidase-4 (DPP-4): A target to treat type 2 diabetes